首页/数据集/Cutaneous Immune-related Adverse Events are Associated with Longer Overall Survival Among Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors

Cutaneous Immune-related Adverse Events are Associated with Longer Overall Survival Among Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors

NIAID Data Ecosystem2026-03-14 收录

肿瘤免疫治疗

免疫相关不良事件

数据链接：

https://data.mendeley.com/datasets/4pgmpzw7ck 数据链接链接失效反馈

官方服务：

资源简介：

Supplemental files

应用场景：

创建时间：

2023-01-17

相关数据集

PD1-PD-L1 C sarc.xlsx

肿瘤免疫治疗

肺肉瘤样癌

PD-L1 & PD1 in lung sarcomatoid carcinoma

Mendeley Data2024-06-25 更新430

Supplementary Material for: Giant cell temporal arteritis followed by severe encephalopathy induced by immunotherapy in a patient with metastatic renal cell carcinoma achieving durable partial response: A case report

免疫相关不良事件

肾细胞癌治疗

Introduction: Combined immune-oncology (IO) regimens are the cornerstone of the current front-line systemic therapy for metastatic renal cell carcinoma (mRCC). Despite the fact that combined IO regime

NIAID Data Ecosystem00

Table 1_PIK3CA mutation–induced immune microenvironment remodeling sensitizes cervical cancer to immunotherapy.xlsx

肿瘤免疫治疗

PIK3CA突变生物标志物

PIK3CA is one of the most frequently mutated genes in cervical cancer (CC). However, its clinical utility is hampered by paradoxical treatment-dependent outcomes, restricting its application in precis

NIAID Data Ecosystem00

DataSheet4_A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1).ZIP

癌症生物标志物

肿瘤免疫治疗

It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, includin

NIAID Data Ecosystem00

Unleashing natural IL-18 activity using an anti-IL-18BP blocker antibody induces potent immune stimulation and anti-tumor effects

肿瘤免疫治疗

单细胞转录组学

Recombinant cytokines have limited anti-cancer efficacy mostly due to narrow therapeutic window and systemic adverse effects. IL-18 is an inflammasome induced proinflammatory cytokine that enhances T

NIAID Data Ecosystem00